Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.

Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.

Item
http://www.wikidata.org/entity/Q36179390
Promising oncolytic agents for metastatic breast cancer treatmentExperimental evolution of an oncolytic vesicular stomatitis virus with increased selectivity for p53-deficient cells.A novel immunocompetent murine model for replicating oncolytic adenoviral therapy.The systemic delivery of an oncolytic adenovirus expressing decorin inhibits bone metastasis in a mouse model of human prostate cancer.Ad5/48 hexon oncolytic virus expressing sTGFβRIIFc produces reduced hepatic and systemic toxicities and inhibits prostate cancer bone metastases.Systemic Delivery of an Oncolytic Adenovirus Expressing Decorin for the Treatment of Breast Cancer Bone MetastasesCombinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy.Magnetic nanoparticles as a new approach to improve the efficacy of gene therapy against differentiated human uterine fibroid cells and tumor-initiating stem cellsAdvanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Signaling between tumor cells and the host bone marrow microenvironment.Immunotherapeutic potential of oncolytic vaccinia virus.Oncolytic Immunotherapy for Treatment of Cancer.Transforming growth factor-β: A therapeutic target for cancer.Viral gene therapy for breast cancer: progress and challenges.TGF-β Inhibition Improves Oncolytic Herpes Viroimmunotherapy in Murine Models of Rhabdomyosarcoma.A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasis.
P2860

Intravenous administration of adenoviruses targeting transforming growth factor beta signaling inhibits established bone metastases in 4T1 mouse mammary tumor model in an immunocompetent syngeneic host.

Item
http://www.wikidata.org/entity/Q36179390
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Intravenous administration of ...... mmunocompetent syngeneic host.
@ast
Intravenous administration of ...... mmunocompetent syngeneic host.
@en
type
label
Intravenous administration of ...... mmunocompetent syngeneic host.
@ast
Intravenous administration of ...... mmunocompetent syngeneic host.
@en
prefLabel
Intravenous administration of ...... mmunocompetent syngeneic host.
@ast
Intravenous administration of ...... mmunocompetent syngeneic host.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
Intravenous administration of ...... mmunocompetent syngeneic host.
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P932